Section 2: Selection, Procurement and Distribution 2019
DOI: 10.1136/ejhpharm-2019-eahpconf.50
|View full text |Cite
|
Sign up to set email alerts
|

2SPD-010 Indirect comparison of pembrolizumab plus chemotherapy versus pembrolizumab in lung cancer

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Year Published

2022
2022
2022
2022

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
references
References 0 publications
0
0
0
Order By: Relevance